Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 423-430

  Kato, Tatsuya ^a,b   Daigo, Yataro ^c   Aragaki, Masato ^a   Ishikawa, Keidai ^a   Sato, Masaaki ^d   Kaji, Mitsuhito ^a  

^a Sapporo Minami Sanjo Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Nippon Telegraph and Telegraph and Telephone East Corporation   (Japan)

Author keywords

CDC20; immunohistochemistry; MAD2; non small cell lung cancer; prognostic factor; spindle checkpoint

Indexed keywords

CELL CYCLE PROTEIN 20; PROTEIN MAD2;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84865135210     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23109     Document Type: Article

References (35)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al.: Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36. (Pubitemid 32166444)
2. Hanahan D, Weinberg RA:, The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
3. Wasch R, Engelbert D:, Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells. Oncogene 2005; 24: 1-10. (Pubitemid 40143858)
4. Morgan DO:, Regulation of the APC and the exit from mitosis. Nat Cell Biol 1999; 1: E47-E53.
5. Peters JM:, The anaphase-promoting complex: Proteolysis in mitosis and beyond. Mol Cell 2002; 9: 931-943. (Pubitemid 34626665)
6. Bharadwaj R, Yu K:, The spindle checkpoint, aneuploidy, and cancer. Oncogene 2004; 23: 2016-2027. (Pubitemid 38496731)
7. Mondal G, Sengupta S, Panda CK, et al.: Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 2007; 28: 81-92. (Pubitemid 44942629)
8. Rajagopalan H, Lengauer C:, Aneuploidy and cancer. Nature 2004; 432: 338-341. (Pubitemid 39551662)
9. Pihan GA, Doxsey SJ:, The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol 1999; 9: 289-302. (Pubitemid 29429993)
10. Mondal G, Baral RN, Roychoudhury S:, A new Mad2-interacting domain of Cdc20 is critical for the function of Mad2-Cdc20 complex in the spindle assembly checkpoint. Biochem J 2006; 396: 243-253. (Pubitemid 43837240)
11. Kato T, Daigo Y, Aragaki M, et al.: Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients. Lung Cancer 2011; 74: 124-131.
12. Kim JM, Sohn HY, Yoon SY, et al.: Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 2005; 11: 473-482. (Pubitemid 40116869)
13. Marucci G, Morandi L, Magrini E, et al.: Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. Virchows Arch 2008; 453: 599-609.
14. Zaravinos A, Lambrou GI, Boulalas I, et al.: Identification of common differentially expressed genes in urinary bladder cancer. PLoS One 2011; 6: e18135.
15. Rajkumar T, Sabitha K, Vijayalakshmi N, et al.: Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer 2011; 11: 80.
16. Ouellet V, Guyot MC, Le Page C, et al.: Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer 2006; 119: 599-607. (Pubitemid 43955714)
17. Rhodes DR, Yu J, Shanker K, et al.: Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101: 9309-9314. (Pubitemid 38812872)
18. Carter SL, Eklund AC, Kohane IS, et al.: A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006; 38: 1043-1048. (Pubitemid 44325930)
19. Singhal S, Amin KM, Kruklitis R, et al.: Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol Ther 2003; 2: 291-298.
20. Takada M, Tada M, Tamoto E, et al.: Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer. J Surg Res 2004; 122: 61-69. (Pubitemid 39441234)
21. Travis WD, Colby TV, Corrin B, et al.: " International Histological Classification of Tumours." Genova: World Health Organization; 1999.
22. Sobin L, Wittekind C:, " TNM Classification of Malignant Tumours.". New York: Wiley-Liss, Inc; 2002.
23. Nagashio R, Sato Y, Matsumoto T, et al.: Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas. Lung Cancer 2009; 69: 54-59.
24. King RW, Peters JM, Tugendreich S, et al.: A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 1995; 81: 279-288.
25. Sudakin V, Ganoth D, Dahan A, et al.: The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 1995; 6: 185-197.
26. Tugendreich S, Tomkiel J, Earnshaw W, et al.: CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition. Cell 1995; 81: 261-268.
27. Nigg EA:, Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2: 21-32. (Pubitemid 33676958)
28. Geley S, Kramer E, Gieffers C, et al.: Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol 2001; 153: 137-148.
29. Yeong FM, Lim HH, Padmashree CG, et al.: Exit from mitosis in budding yeast: Biphasic inactivation of the Cdc28-Clb2 mitotic kinase and the role of Cdc20. Mol Cell 2000; 5: 501-511.
30. Stemmann O, Zou H, Gerber SA, et al.: Dual inhibition of sister chromatid separation at metaphase. Cell 2001; 107: 715-726. (Pubitemid 34033665)
31. Wasch R, Cross FR:, APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit. Nature 2002; 418: 556-562. (Pubitemid 34851404)
32. Kikuchi T, Daigo Y, Katagiri T, et al.: Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 2003; 22: 2192-2205. (Pubitemid 36539569)
33. De Antoni A, Pearson CG, Cimini D, et al.: The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Curr Biol 2005; 15: 214-225. (Pubitemid 40205701)
34. McDoniels-Silvers AL, Nimri CF, Stoner GD, et al.: Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002; 8: 1127-1138. (Pubitemid 35177366)
35. Petty RD, Nicolson MC, Kerr KM, et al.: Gene expression profiling in non-small cell lung cancer: From molecular mechanisms to clinical application. Clin Cancer Res 2004; 10: 3237-3248. (Pubitemid 38685427)